Where do things stand with IPS cell translational research? The newest development is that regulators in Japan just have given conditional approval to an Osaka University team to an induced pluripotent stem (IPS) cell-based study for ischemic heart disease. For years […]
Just how good are today’s iPS cells? Are they essentially functionally the same as ES cells? Take our polls below to let us know your thoughts.